Skip to main content

Lifecore Biomedical, Inc. De 8-K, filed Nov 4, 2026

Lifecore Biomedical, Inc. De (LFCR)

8-K 2026-11-04 For: 2026-11-04
View Original
Added on November 04, 2026

About this 8-K

Lifecore Biomedical, Inc. De filed this 8-K on November 4, 2026.

Lifecore Biomedical reported third-quarter revenue of $25.3 million, down 18.6%, and net loss of $40.1 million for the period ended September 30, 2026. Nine-month revenue was $82.7 million, down 21.8%; liquidity totaled approximately $38.0 million. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits